Skip to main content

NPF Endorsed Features

Sonya Zarkhin, DO, Nichelle Madden, DO, Kristi Hawley, DO, Sean Stephenson, DO
Linear psoriasis, a rare variant of psoriasis, is not well understood, but its course of treatment is similar to other psoriatic presentations. The authors report a successfully treated case of linear psoriasis in a 19-year-old female patient.
Lauren Mateja, Managing Editor
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass on to their patients.
Lauren Mateja, Managing Editor
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
Lauren Mateja, Managing Editor
It is hypothesized that psoriatic arthritis is too often underdiagnosed, and therefore undertreated, in dermatology. In an interview with The Dermatologist, Drs Joseph F. Merola and Alice B. Gottlieb shared their insights as dual dermatologist-rheumatologists on screening for psoriatic arthritis in the patient with psoriasis.
Lauren Mateja, Managing Editor
Psoriasis can affect patients at all walks of life, from children to the elderly. Adolescents, however, require special considerations, from psychosocial conditions to therapy options, for the short- and long-term management of psoriasis.
Melissa Weiss, Associate Editor, Lauren Mateja, Managing Editor
Several breakthrough studies and prominent clinical guidelines related to psoriasis were published in 2019. Review some of the most impactful psoriasis content published this year.
Melissa Weiss, Associate Editor
The American Academy of Dermatology and National Psoriasis Foundation released new guidelines on the use of phototherapy for the treatment of psoriasis. Joel Gelfand, MD, MSCE, discussed the updated guidelines with The Dermatologist.
Peter Sonnenreich; Bassem Wolley; and Katherine Moody, Contributing Writers
Certain comorbidities—particularly congestive heart failure, tuberculosis, and HIV infection—can affect the type of psoriasis treatment physicians recommend to their patients.
Melissa Weiss, Associate Editor
Access restrictions to therapies among patients with rheumatoid arthritis and psoriatic arthritis can significantly impact treatment effectiveness and adherence. Natalie Boytsov, PhD, discussed the implications of these restrictions with The Dermatologist.
Melissa Weiss, Associate Editor
Dermatologists have another weapon in their arsenal to prescribe for patients with mild plaque psoriasis.
Back to Top